To hear about similar clinical trials, please enter your email below

Trial Title: HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients

NCT ID: NCT05510388

Condition: Gastric Cancer
Intestinal Cancer
Intestine Adenoma
Gastritis

Conditions: Official terms:
Adenoma
Intestinal Neoplasms
Gastritis
Hypoxia

Conditions: Keywords:
Gastroscopy
High-flow nasal oxygenation
Hypoxia
High-risk
Colonoscopy

Study type: Interventional

Study phase: N/A

Overall status: Unknown status

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Prevention

Masking: Single (Participant)

Intervention:

Intervention type: Device
Intervention name: High-flow nasal cannula oxygenation
Description: The patients receive oxygen flow of 6L/min for preoxygenation with an high-flow canular oxygenation device before losing of conscious. Then, the oxygen flow is adjusted to 60L/min with the oxygen concentration of 100% and the temperature of 37℃ until the end of procedure.
Arm group label: High-flow nasal cannula oxygenation group

Intervention type: Device
Intervention name: Regular nasal cannula oxygenation
Description: The patients receive an oxygen flow of 6L/min for preoxygenation with a disposal regular nasal cannula until the end of procedure.
Arm group label: Regular nasal cannula oxygenation group

Summary: The objective of this study is to observe the preventive effects of high flow nasal oxygenation on the incidence of hypoxia during gastroscopy or colonoscopy sedated with propofol in high-risk patients.

Criteria for eligibility:
Criteria:
Inclusion Criteria: 1. Age ranging from 18 to 80, both sexes 2. Patients receiving selective gastroscopy or colonoscopy or gastroscopy and colonoscopy procedure 3. ASA Ⅲ~Ⅳ 4. 18 kg/m2

Gender: All

Minimum age: 18 Years

Maximum age: 80 Years

Healthy volunteers: No

Locations:

Facility:
Name: The Second Hospital Affiliated to Chongqing Medical University

Address:
City: Chongqing
Zip: 404100
Country: China

Contact:
Last name: He Huang

Facility:
Name: Henan Provincial people's hospital

Address:
City: Zhengzhou
Zip: 450000
Country: China

Contact:
Last name: Jiaqiang Zhang

Start date: September 1, 2022

Completion date: June 30, 2023

Lead sponsor:
Agency: RenJi Hospital
Agency class: Other

Source: RenJi Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05510388

Login to your account

Did you forget your password?